Press releasePRNewswire
Boston Scientific
BSX · NYSE
$45.58+$0.53 (+1.18%)TodayMarket closed ·
Prev close $45.05
News sentiment
Tone of recent coverage
Social media sentiment, last 30 days
Average tone of posts mentioning BSX, from −1 (all negative) to +1 (all positive). Latest day: −0.50 across 22 mentions.
Latest news
- Press releaseGlobe Newswire
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
- NewsVandana Singh
FDA Flags Boston Scientific Catheter Recall
- NewsTim Melvin
Alpha Buying: 4 Falling Knives Insiders Are Buying
- NewsVandana Singh
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
- NewsVandana Singh
Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk
- NewsVandana Singh
Boston Scientific Reports Global Disruption After Cybersecurity Incident
- NewsPiero Cingari
Nasdaq 100 Falls as Hot PCE Inflation Stirs Rate-Hike Bets: Stock Market Today
- Press releasePRNewswire
Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results
- Press releasePRNewswire
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
- NewsVandana Singh
Boston Scientific Cuts Forecast on Product Slowdown and Competition
- News
Boston Scientific Q2 Adj. EPS $0.86 Beats $0.83 Estimate, Sales $5.442B Beat $5.361B Estimate
- Press releasePRNewswire
Boston Scientific announces results for second quarter 2026
- NewsErica Kollmann
'Selling Winners, Buying Losers': Tech Stocks Drop as Energy Jumps to Start H2
- NewsAvi Kapoor
Cramer Passes On NioCorp And SoundHound — But Says One Stock Is 'Time To Buy'
- NewsPiero Cingari
Dow Jones Hit Records Above 50,600 As Oil Sinks Below $90: Stock Market Today
- NewsVandana Singh
Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results
- Press releasePRNewswire
FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints
- NewsVandana Singh
Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal
- Press releasePRNewswire
Boston Scientific enters into $2 billion accelerated share repurchase agreement
- News
Boston Scientific Spends $1.5B To Acquire A ~34% Stake In MiRus LLC, A Developer Of Proprietary Biomaterials And Implants
- Press releasePRNewswire
Boston Scientific announces strategic investment in MiRus LLC
- NewsTanya Rawat
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
- News
10 Health Care Stocks Whale Activity In Today's Session
- Press releaseBusiness Wire
BSX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
- Press releasePRNewswire
Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results
- Press releasePRNewswire
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
- Press releaseGlobe Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 4, 2026 in Boston Scientific Corporation Lawsuit - BSX
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX
- Press releaseBusiness Wire
Deadline Soon: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
- Press releasePRNewswire
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented U.S. Electrophysiology Market Growth and Downplayed Competitive Pressures: SueWallSt
- Press releaseGlobe Newswire
Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
- Press releasePRNewswire
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Hid Weakening U.S. Electrophysiology Sales Trends: Levi & Korsinsky
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
- Press releasePRNewswire
Lost Money on Boston Scientific Corporation (BSX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
- Press releasePRNewswire
BSX Deadline: BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
- News
A Look Into Boston Scientific Inc's Price Over Earnings
- News
A Look Into Boston Scientific Inc's Price Over Earnings
- News
Price Over Earnings Overview: Boston Scientific
- Press releasePRNewswire
Boston Scientific announces results for fourth quarter and full year 2024
- Press releasePRNewswire
Boston Scientific Announces Results for Third Quarter 2024
- Press releasePRNewswire
Boston Scientific Announces Results for Second Quarter 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.